Bronchoscopes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Use (Reusable, Disposable), By Type (Rigid, Flexible), By Region and Competition, 2020-2030F

Market Overview

The Global Bronchoscopes Market, valued at USD 16.28 Billion in 2024, is projected to experience a CAGR of 7.96% to reach USD 25.78 Billion by 2030. Bronchoscopes are essential medical instruments employed for visualizing the tracheobronchial tree, facilitating diagnostic examinations, and performing therapeutic interventions within the airways. The market’s expansion is primarily driven by the escalating global prevalence of chronic respiratory diseases, an aging demographic more susceptible to pulmonary conditions, and the increasing adoption of minimally invasive diagnostic and interventional procedures. For instance, according to a joint report by WHO/Europe and the European Respiratory Society, published in 2025, approximately 81.7 million people in the WHO European Region are living with chronic respiratory diseases, underscoring a substantial patient pool requiring advanced diagnostic and interventional tools.

However, a significant impediment to market growth remains the substantial upfront capital expenditure associated with acquiring and maintaining advanced bronchoscope systems. This financial barrier can restrict adoption, particularly in emerging economies and healthcare facilities operating under stringent budgetary constraints, thereby challenging broader market penetration and expansion efforts.

Key Market Drivers

The increasing prevalence of respiratory diseases significantly fuels the global bronchoscopes market by expanding the patient pool requiring diagnostic and therapeutic interventions. Conditions such as lung cancer, chronic obstructive pulmonary disease, and asthma necessitate bronchoscopic examinations for accurate diagnosis, staging, and treatment planning. This growing disease burden directly correlates with increased demand for instruments capable of visualizing the tracheobronchial tree, facilitating early detection and improved patient management. For instance, according to the World Health Organization, in February 2024, lung cancer was the most commonly occurring cancer worldwide with 2.5 million new cases, underscoring the substantial global need for advanced diagnostic tools. The rising incidence rates of these pulmonary conditions mandate more frequent and precise bronchoscopic procedures, thereby stimulating market expansion for both reusable and disposable devices.

Advancements in bronchoscopy technology represent another pivotal driver, enhancing procedural efficacy, safety, and expanding clinical applications. Innovations in imaging capabilities, device miniaturization, and improved maneuverability allow for more detailed visualization and access to peripheral airways, thereby improving diagnostic yields and therapeutic outcomes. For example, according to Olympus, in May 2024, the launch of its BF-H1100 diagnostic bronchoscope within the EVIS X1 Endoscopy System featured a 2.2mm working channel, which provides an 11% increase in suction capability compared to predecessors. Such technological enhancements contribute to greater adoption rates across healthcare settings, further bolstered by increasing hospital investments in specialized facilities. According to Bradford Teaching Hospitals NHS Foundation Trust, in October 2024, a new state-of-the-art endoscopy unit involving a £25 million investment commenced construction at Bradford Royal Infirmary, designed to expand capacity and reduce waiting lists. These combined factors accelerate the market for bronchoscopes.

Download Free Sample Report

Key Market Challenges

The substantial upfront capital expenditure required for acquiring and maintaining advanced bronchoscope systems presents a considerable impediment to the Global Bronchoscopes Market's expansion. This financial barrier limits the adoption of state-of-the-art diagnostic and interventional tools, particularly within emerging economies and healthcare facilities operating under severe budgetary constraints. Such high costs directly constrain purchasing power, delaying necessary upgrades and inhibiting broader market penetration for innovative bronchoscope technologies, thereby slowing overall market growth.

The impact of this financial burden is evident in broader healthcare capital spending trends. According to the American Hospital Association's 2024 "Costs of Caring" report, the average age of capital investments for medical equipment and infrastructure across all hospitals increased by 7.1% in 2023. This upward trend in equipment age indicates a deferral of new acquisitions, including specialized instruments like bronchoscopes, as institutions grapple with resource allocation. The need to balance competing financial priorities directly curtails investments in new bronchoscope systems, constraining their market uptake.

Key Market Trends

The increasing adoption of single-use bronchoscopes is driven by infection control and operational efficiencies. These devices provide a sterile instrument per patient, addressing cross-contamination risks and eliminating complex reprocessing, enhancing patient safety and reducing logistical burdens. Research in the AME Medical Journal in April 2024 indicated that reprocessed reusable flexible bronchoscopes, despite strict guidelines, showed microbial contamination in over 28% of cases, underscoring the need for disposable options. This imperative drives demand. Ambu, in its Q3 2024/25 interim report published in August 2025, reported its Endoscopy Solutions business achieved 15.9% organic revenue growth, driven by continued aScope 5 Broncho and other single-use devices adoption.

The expansion of robotic-assisted bronchoscopy signifies a notable advancement, offering enhanced precision and improved navigation to peripheral lung lesions. This technology provides greater dexterity and stability, enabling more accurate biopsies and therapeutic interventions than manual bronchoscopy. Robotic systems integrate advanced imaging and navigation software, guiding instruments with millimetric precision. The American Association for Bronchology and Interventional Pulmonology notably expanded its educational offerings, with its "IP Fellows Bootcamp" and "Mid-Year Advanced Therapeutic Bronchoscopy and Thoracoscopy Course" scheduled for multiple dates across 2024 and 2025, including July 2024, February 2025, and July 2025, indicating growing professional adoption. Johnson & Johnson MedTech, in June 2025, announced results from its TARGET study for the Monarch platform, showing clinicians reached peripheral lung nodules in over 98% of cases, highlighting the system's efficacy.

Segmental Insights

The Disposable segment is experiencing rapid growth within the Global Bronchoscopes Market. This expansion is predominantly fueled by the crucial need for superior infection control, as single-use devices inherently eliminate the risk of cross-contamination and hospital-acquired infections, a primary concern for healthcare institutions and regulatory bodies globally. The disposable nature also streamlines clinical workflows by negating complex reprocessing procedures, ensuring immediate device availability and reducing operational overhead. Concurrently, the increasing global prevalence of respiratory diseases, such as chronic obstructive pulmonary disease and lung cancer, significantly boosts the demand for safe diagnostic and therapeutic bronchoscopy.

Regional Insights

North America holds a leading position in the Global Bronchoscopes Market due to several distinct factors. The region benefits from a significant burden of chronic respiratory diseases, including COPD and lung cancer, necessitating frequent diagnostic and therapeutic bronchoscopy procedures. This is further supported by well-developed healthcare infrastructure and the swift adoption of advanced medical technologies for minimally invasive interventions. Additionally, favorable reimbursement policies in countries like the United States, along with the presence of major industry participants and a robust regulatory environment exemplified by the U. S. Food and Drug Administration, collectively contribute to North America's market dominance.

Recent Developments

• In October 2025, Intuitive received U.S. Food and Drug Administration (FDA) clearance for software enhancements to its Ion endoluminal robotic bronchoscopy system. These advancements integrated artificial intelligence across the system's entire navigational workflow and incorporated new advanced imaging capabilities, including integrated tomosynthesis. The updates were designed to support more accurate and efficient lung biopsies by providing real-time imaging information with a standard C-arm, thereby broadening access to advanced imaging options for physicians.

• In September 2025, Olympus Corporation launched its latest endobronchial ultrasound (EBUS) bronchoscope, the BF-UCP190F, in the EMEA and Asia-Pacific markets, with a subsequent launch planned for Japan. This new bronchoscope was characterized by a slim design and enhanced maneuverability, specifically engineered to improve precision in acquiring tissue from deeper lung regions. This innovation was aimed at facilitating more accurate diagnostic assessments for various lung conditions, including lung cancer, by extending the reach of EBUS-guided needle aspiration procedures.

• In August 2024, Ambu showcased its aScope 5 Broncho series, highlighting new Thin and Ultrathin single-use flexible bronchoscopes. These additions were developed to support advanced diagnostic and therapeutic procedures, particularly in peripheral airways and smaller anatomies. The Thin bronchoscope provided a regular-sized working channel for instruments, while the Ultrathin model was noted as the first single-use scope of its size to include a working channel. The introduction aimed to provide consistent performance and sterility for complex bronchoscopy workflows.

• In May 2024, Olympus Corporation introduced two new bronchoscopes as part of its EVIS X1 Endoscopy System. These diagnostic and therapeutic bronchoscopes were designed with high-definition imaging capabilities and featured a slim outer diameter compared to previous models. This advancement allowed for enhanced access to more distal airways, alongside improved suction and flexibility during procedures. The new designs facilitated the passage of various diagnostic and therapeutic devices through larger working channels, offering physicians expanded options for addressing the tracheobronchial tree.

Key Market Players

• Teleflex Incorporated
• Olympus Corporation
• Ambu A/s
• Karl Storz SE & Co. KG
• Fujifilm Holdings Corporation
• Boston Scientific Corporation
• Cogentix Medical, Inc.
• Broncus Medical Inc.
• Lymol Medical Corporation
• Novatech SA

Report Scope:

In this report, the Global Bronchoscopes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Bronchoscopes Market, By Use:

o   Reusable

o   Disposable

• Bronchoscopes Market, By Type:

o   Rigid

o   Flexible

• Bronchoscopes Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Bronchoscopes Market.

Available Customizations:

Global Bronchoscopes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Bronchoscopes Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]